AArkstore enterprise 7th Novenber 2014
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60335/growth-hormone-deficiencyghd-therapeutics-pipeline-assessment-and-market-forecasts Published: Jan 2012 | No. Of Pages: 74 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Summary Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Summary the industry analysis specialist, has released its new report, Growth Hormone Deficiency (GHD) Therapeutics Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global Growth Hormone Deficiency (GHD) Therapeutics market. The report identifies the key trends shaping and driving the global Growth Hormone Deficiency (GHD) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Growth Hormone Deficiency (GHD) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Website : http://www.aarkstore.com/
AArkstore enterprise Scope The report provides information on the key drivers and challenges of the Growth Hormone Deficiency (GHD) Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Growth Hormone Deficiency (GHD) Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Growth Hormone Deficiency (GHD) Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Growth Hormone Deficiency (GHD) Therapeutics market. - Analysis of key recent licensing and partnership agreements in Growth Hormone Deficiency (GHD) Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Growth Hormone Deficiency (GHD) Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Growth Hormone Deficiency (GHD) Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Website : http://www.aarkstore.com/
AArkstore enterprise - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - Whats the next big thing in the global Growth Hormone Deficiency (GHD) Therapeutics market landscape? Identify, understand and capitalize.
Tables Of Contents 2 Growth Hormone Deficiency (GHD) Therapeutics - Introduction 2.1 Disease Overview 2.2 Epidemiology 2.3 Etiology 2.4 Pathophysiology 2.5 Signs and Symptoms 2.5.1 Children 2.5.2 Adults 2.6 Commonly Used Diagnostic Tests 2.6.1 Growth Hormone Response is Measured against Insulin Induced Hypoglycemia 2.6.2 Growth Hormone Response to Arginine/Growth Hormone Releasing Hormone (GHRH) Infusion 2.6.3 Radiological Investigations 2.7 Treatment and Management Options for Growth Hormone Deficiency 2.7.1 Factors affecting GH dosing 2.7.2 GH replacement therapy in adults with GHD 2.7.3 GH replacement therapy in children with GHD
Website : http://www.aarkstore.com/
AArkstore enterprise 2.8 GlobalData Pipeline Report Guidance 3 GHD Therapeutics - Market Characterization 3.1 GHD Therapeutics Market Size (2005-2010) - Global 3.2 GHD Therapeutics Market Forecast (2010-2018) - Global 3.3 GHD Therapeutics Market Size (2005-2010) - The US 3.4 GHD Therapeutics Market Forecast (2010-2018) - The US 3.5 GHD Therapeutics Market Size (2005-2010) - France 3.6 GHD Therapeutics Market Forecast (2010-2018) - France 3.7 GHD Therapeutics Market Size (2005-2010) - Germany 3.8 GHD Therapeutics Market Forecast (2010-2018) - Germany 3.9 GHD Therapeutics Market Size (2005-2010) - Italy 3.10 GHD Therapeutics Market Forecast (2010-2018) - Italy 3.11 GHD Therapeutics Market Size (2005-2010) - Spain 3.12 GHD Therapeutics Market Forecast (2010-2018) - Spain 3.13 GHD Therapeutics Market Size (2005-2010) - The UK 3.14 GHD Therapeutics Market Forecast (2010-2018) - The UK 3.15 GHD Therapeutics Market Size (2005-2010) - Japan 3.16 GHD Therapeutics Market Forecast (2010-2018) - Japan 3.17 Drivers and Barriers for the GHD Therapeutics Market 3.17.1 Drivers for the GHD Therapeutics Market 3.17.2 Barriers for the GHD Therapeutics Market 3.18 Opportunity and Unmet Need Analysis 3.19 Key Takeaway
Website : http://www.aarkstore.com/
AArkstore enterprise 4 GHD Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the GHD Therapeutics Market 4.3.1 Nutropin AQ 4.3.2 Humatrope 4.3.3 Genotropin 4.3.4 Saizen 4.3.5 Norditropin 4.3.6 Omnitrope 4.3.7 Increlex 4.4 Key Takeaway 5 GHD Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 GHD Therapeutics Pipeline - Pipeline by Phases of Development 5.3.1 GHD Therapeutics -Regulatory Filed and Phase III Clinical Pipeline 5.3.2 GHD Therapeutics - Phase II Pipeline 5.3.3 GHD Therapeutics - Phase I Pipeline 5.3.4 GHD Therapeutics - Preclinical 5.3.5 GHD Therapeutics - Discovery 5.3.6 GHD Therapeutics - Unknow Phase 5.3.7 Technology Trends Analytic Framework
Website : http://www.aarkstore.com/
AArkstore enterprise 5.4 GHD Therapeutics Market - Pipeline by Mechanism of Action 5.5 GHD Therapeutics - Promising Drugs in Clinical Development 5.6 Molecule Profile for Promising Drugs in Clinical Development 5.6.1 LB03002 (SR-recombinant hGH) 5.7 Key Takeaway 6 GHD Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region and Country 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Clinical Trials Mapping by Sponsors 6.5 Prominent Sponsors 6.6 Top Companies Participating in GHD Therapeutics Clinical Trials 7 GHD Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 GHD Therapeutics: Implications for Future Market Competition 8 GHD Therapeutics Market - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 BioPartners GmbH 8.2.2 LG Life Sciences, Ltd. 8.2.3 Ipsen S.A. 8.2.4 EMD Serono, Inc. 8.2.5 Theratechnologies Inc.
Website : http://www.aarkstore.com/
AArkstore enterprise 8.2.6 Eli Lilly and Company 8.2.7 Ambrx, Inc. 9 GHD Therapeutics - Licensing and Partnership Deals 10 GHD Therapeutics - Appendix 10.1 Market Definitions 10.2 Acronyms 10.3 Research Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Major Marketed Products in The US and EU5 Table 2: GH Replacement Therapy in Adults with GHD Table 3: GHD Therapeutics Market, Global, Revenue ($m), 2005-2010 Table 4: GHD Therapeutics Market, Global, Forecast ($m), 2010-2018 Table 5: GHD Therapeutics Market, The US, Revenue ($m), 2005-2010 Table 6: GHD Therapeutics Market, The US, Forecasts ($m), 2010-2018 Table 7: GHD Therapeutics Market, France, Revenue ($m), 2005-2010
Website : http://www.aarkstore.com/
AArkstore enterprise Table 8: GHD Therapeutics Market, France, Forecasts ($m), 2010-2018 Table 9: GHD Therapeutics Market, Germany, Revenue ($m), 2005-2010 Table 10: GHD Therapeutics Market, Germany, Forecasts ($m), 2010-2018 Table 11: GHD Therapeutics Market, Italy, Revenue ($m), 2005-2010 Table 12: GHD Therapeutics Market, Italy, Forecasts ($m), 2010-2018 Table 13: GHD Therapeutics Market, Spain, Revenue ($m), 2005-2010 Table 14: GHD Therapeutics Market, Spain, Forecasts ($m), 2010-2018 Table 15: GHD Therapeutics Market, The UK, Revenue ($m), 2005-2010 Table 16: GHD Therapeutics Market, The UK, Forecasts ($m), 2010-2018 Table 17: GHD Therapeutics Market, Japan, Revenue ($m), 2005-2010 Table 18: GHD Therapeutics Market, Japan, Forecasts ($m), 2010-2018 Table 19: Pharmaceutical Companys Patient Assistance Programs Table 20: Major Marketed Products in GHD Therapeutics Market Table 21: GHD Therapeutics- Regulatory Filed and Phase III Pipeline, 2011 Table 22: GHD Therapeutics - Phase II Pipeline, 2011 Table 23: GHD Therapeutics - Phase I Pipeline, 2011 Table 24: GHD Therapeutics - Preclinical Phase Pipeline, 2011 Table 25: GHD Therapeutics - Discovery Phase Pipeline, 2011 Table 26: GHD Therapeutics - Unknown Phase, 2011 Table 27: GHD Therapeutics - Most Promising Drug In Clinical Development, 2011 Table 28: GHD Therapeutics - Clinical Trials by Country, 2011 Table 29: GHD Therapeutics - Clinical Trials by Phase, 2011 Table 30: GHD Therapeutics - Clinical Trials by Status, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Table 31: GHD Therapeutics - Overall Sponsors, 2011 Table 32: GHD Therapeutics - Prominent Sponsors, 2011 Table 33: GHD Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 Table 34: BioPartners GmbH, Pipeline - 2011 Table 35: LG Life Sciences, Pipeline- 2011 Table 36: Ipsen S.A., Pipeline- 2011 Table 37: EMD Serono, Inc., Pipeline- 2011 Table 38: Theratechnologies Inc., Pipeline- 2011 Table 39: Ambrx, Inc., Pipeline- 2011 Table 40: GHD-Global, Deals, 2011
List Of Figures Figure 1: Etiology of Growth Hormone Deficiency Figure 2: Re-evaluation of GH and IGF-1 Levels- End of Growth in GHD Children Figure 3: GHD Therapeutics Market, Global, Revenue ($m), 2005-2010 Figure 4: GHD Therapeutics Market, Global, Forecast ($m), 2010-2018 Figure 5: GHD Therapeutics Market, The US, Forecast ($m), 2005-2010 Figure 6: GHD Therapeutics Market, The US, Forecasts ($m), 2010-2018 Figure 7: GHD Therapeutics Market, France, Revenue ($m), 2005-2010 Figure 8: GHD Therapeutics Market, France, Forecast ($m), 2010-2018 Figure 9: GHD Therapeutics Market, Germany, Revenue ($m), 2005-2010 Figure 10: GHD Therapeutics Market, Germany, Forecast ($m), 2010-2018 Figure 11: GHD Therapeutics Market, Italy, Revenue ($m), 2005-2010 Figure 12: GHD Therapeutics Market, Italy, Forecast ($m), 2010-2018
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 13: GHD Therapeutics Market, Spain, Revenue ($m), 2005-2010 Figure 14: GHD Therapeutics Market, Spain, Forecast ($m), 2010-2018 Figure 15: GHD Therapeutics Market, The UK, Revenue ($m), 2005-2010 Figure 16: GHD Therapeutics Market, The UK, Forecast ($m), 2010-2018 Figure 17: GHD Therapeutics Market, Japan, Revenue ($m), 2005-2010 Figure 18: GHD Therapeutics Market, Japan, Forecasts ($m), 2010-2018 Figure 19: Barriers To The Development of Biogenerics Figure 20: Opportunity and Unmet Need in the GHD Therapeutics Market Figure 21: GHD Therapeutics - Strategic Competitor Assessment, 2011 Figure 22: GHD Therapeutics - Pipeline by Phase of Development, 2011 Figure 23: GHD Therapeutics - Technology Trends Analytics Framework, 2011 Figure 24: GHD Therapeutics - Technology Trends Analytics Framework - Description, 2011 Figure 25: GHD Therapeutics - Pipeline by Mechanism of Action, 2011 Figure 26: GHD Therapeutics - Clinical Trials by Country, 2011 Figure 27: GHD Therapeutics - Clinical Trials by Phase, 2011 Figure 28: GHD Therapeutics - Clinical Trials by Status, 2011 Figure 29: GHD Therapeutics- Overall Sponsors, 2011 Figure 30: GHD Therapeutics - Prominent Sponsors, 2011 Figure 31: GHD Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 Figure 32: GHD Therapeutics Market, Drivers and Barriers, 2011 Figure 33: Implications for Future Market Competition in the GHD Therapeutics Market, 2011 Figure 34: GHD Therapeutics Market- Clinical Pipeline by Company, 2011 Figure 35: GlobalData Market Forecasting Model
Website : http://www.aarkstore.com/
AArkstore enterprise Related reports: WhanIn Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2014 TransTech Pharma, Inc. - Product Pipeline Review - 2014 Lipopharma Therapeutics SL - Product Pipeline Review - 2014 Evolva SA - Product Pipeline Review - 2014 AnaptysBio, Inc. - Product Pipeline Review - 2014 Advanced Cancer Therapeutics - Product Pipeline Review - 2014 Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2014 Domainex Ltd. - Product Pipeline Review - 2014 Circassia Pharmaceuticals plc - Product Pipeline Review - 2014
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60335/growth-hormonedeficiency-ghd-therapeutics-pipeline-assessment-and-market-forecasts
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com
Website : http://www.aarkstore.com/
AArkstore enterprise Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/